Cost-effectiveness of treatment strategies for cervical infection among women at high risk in Madagascar

Sexually Transmitted Diseases

Volumn 34, Issue 9, 2007, Pages 631-637

  McClamroch, Kristi ^a   Behets, Frieda ^b,c   Van Damme, Kathleen ^c   Rabenja, Lovaniaina Ny ^d   Myers, Evan ^e  

^a UNIVERSITY AT ALBANY   (United States)

^b IL   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d UNC MAD   (Madagascar)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC ASPECT; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RATE; LABORATORY TEST; MADAGASCAR; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROBABILITY; RISK; TREATMENT PLANNING; UTERINE CERVICITIS; UTERINE CERVIX;

COST-BENEFIT ANALYSIS; DECISION TREES; FEMALE; GUIDELINES; HUMANS; MADAGASCAR; NATIONAL HEALTH PROGRAMS; OUTCOME ASSESSMENT (HEALTH CARE); PROSTITUTION; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL DISEASES;

EID: 34548167346     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000258107.75888.0e     Document Type: Article

References (24)

1. Kruse N, Behets F, Vaovola G, et al. Participatory mapping of sex trade and enumeration of sex workers using capture-recapture methodology in Diego-Suarez, Madagascar. Sex Transm Dis 2003; 30:664-670.
2. Behets F, Andriamiadana J, Rasamilalao D, et al. Sexually transmitted infections and associated socio-demographic and behavioural factors in women seeking primary care suggest Madagascar's vulnerability to rapid HIV spread. Trop Med Int Health 2001; 6:202-211.
3. Behets FM, Rasolofomanana JR, Van Damme K, et al. Evidence-based treatment guidelines for sexually transmitted infections developed with and for female sex workers. Trop Med Int Health 2003;8:251-258.
4. Brunham RC, Plummer FA. A general model of sexually transmitted disease epidemiology and its implications for control. Med Clin North Am 1990; 74:1339-1352.
5. Steen R, Vuylsteke B, DeCoito T, et al. Evidence of declining STD prevalence in a South African mining community following a core-group intervention. Sex Transm Dis 2000; 27:1-8.
6. Horizons Program. Estimating the cost and effectiveness of different STI management strategies for sex workers in Madagascar: Horizons research summary. Washington, DC: Population Council, 2002.
7. DATA 4.0, Computer Program. TreeAge Software I. 2002. 8. Magid D, Douglas JM Jr, Schwartz JS. Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: An incremental cost-effectiveness analysis. Ann Intern Med 1996; 124:389-399.
8. Rustomjee R, Kharsany AB, Connolly CA, et al. A randomized controlled trial of azithromycin versus doxycycline/ciprofloxacin for the syndromic management of sexually transmitted infections in a resource-poor setting. J Antimicrob Chemother 2002; 49:875-878.
9. Hook EW III, Jones RB, Martin DH, et al. Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women. Antimicrob Agents Chemother 1993; 37:1670-1673.
10. Romanowski B, Talbot H, Stadnyk M, et al. Minocycline compared with doxycycline in the treatment of nongonococcal urethritis and mucopurulent cervicitis. Ann Intern Med 1993; 119:16-22.
11. Martin DH, Mroczkowski TF, Dalu ZA, et al. A controlled trial of a single dose of azithromycin for the treatment of chlamydial urethritis and cervicitis. The Azithromycin for Chlamydial Infections Study Group. N Engl J Med 1992; 327:921-925.
12. Westrom LV. Sexually transmitted diseases and infertility. Sex Transm Dis 1994; 21:S32-S37.
13. Mehta SD, Bishai D, Howell MR, et al. Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients. Sex Transm Dis 2002; 29:83-91.
14. Castro-Leal F, Dayton J, Demery L, et al. Public spending on health care in Africa: Do the poor benefit? Bull World Health Organ 2000;78:66-74.
15. Stamm WE, Guinan ME, Johnson C, et al. Effect of treatment regimens for Neisseria gonorrhoeae on simultaneous infection with Chlamydia trachomatis. N Engl J Med 1984; 310:545-549.
16. Welte R, Kretzschmar M, Leidl R, et al. Cost-effectiveness of screening programs for Chlamydia trachomatis: A population-based dynamic approach. Sex Transm Dis 2000; 27:518-529.
17. Shafer MA, Pantell RH, Schachter J. Is the routine pelvic examination needed with the advent of urine-based screening for sexually transmitted diseases? Arch Pediatr Adolesc Med 1999; 153:119-125.
18. Petitta A, Hart SM, Bailey EM. Economic evaluation of three methods of treating urogenital chlamydial infections in the emergency department. Pharmacotherapy 1999; 19:648-654.
19. Vandepitte J, Lyeria R, Dallabetta G, et al. Estimates of the number of female sex workers in different regions of the world. Sex Transm Infect 2006; 82:18-25.
20. World Bank. Summary Gender Profile, Madagascar. Available at http:// devdata.worldbank.org/genderstats/genderRpt.asp?rpt=profile&cty=MDG, Madagascar&hm=home4, http://devdata.worldbank.org/hnpstats/cg.asp. Accessed August 15, 2006.
21. Sahin-Hodoglugil NN, Woods R, Pettifor A, et al. A comparison of cost-effectiveness of three protocols for diagnosis and treatment of gonococcal and chlamydial infections in women in Africa. Sex Transm Dis 2003;30:455-469.
22. Marrazzo JM, Celum CL, Hillis SD, et al. Performance and cost-effectiveness of selective screening criteria for Chlamydia trachomatis infection in women. Implications for a national Chlamydia control strategy. Sex Transm Dis 1997; 24:131-141.
23. Liu H, Jamison D, Li X, et al. Is syndromic management better than the current approach for treatment of STDs in China? Evaluation of the cost-effectiveness of syndromic management for male STD patients. Sex Transm Dis 2003; 30:327-230.
24. Behets FM, Miller WC, Cohen MS. Syndromic treatment of gonococcal and chlamydial infections in women seeking primary care for the genital discharge syndrome: Decision-making. Bull World Health Organ 2001; 79:1070-1075.